A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine

已完结 10 由小明同学发布于 2025/5/9 22:18:47

DOI:10.1126/scitranslmed.adn1441
作者：Christina Dold,?Blanché Oguti,?Laura Silva-Reyes,?Anna Stanzelova,?Meriel Raymond,?Catherine C. Smith,?Maria Moore,?Anna Barton,?Edward M. Choi,?Emma Plested,?Kiarash Tanha,?Jennifer Louth,?Ann Holla
文献类型：期刊论文
补充材料：只需要正文

American Association for the Advancement of Science (AAAS)

Abstract：Capsular group B meningococcus (MenB) remains an important cause of disease globally, and additional vaccines against MenB would aid in reducing the incidence of infection. Previous work has

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Manure treatment and utilization in production systems